Log in to save to my catalogue

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepa...

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ec4cc9154a2f40df8dcaa61493fe4d89

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma

About this item

Full title

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma

Publisher

England: BioMed Central Ltd

Journal title

BMC gastroenterology, 2023-03, Vol.23 (1), p.70-70, Article 70

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Ramucirumab was shown to be effective as a second-line treatment after sorafenib in patients with advanced hepatocellular carcinoma (HCC) with alpha-fetoprotein levels > 400 ng/mL in a worldwide phase 3 trial. Ramucirumab is used in patients pretreated with various systemic therapies in clinical practice. We retrospectively examined the treatment o...

Alternative Titles

Full title

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ec4cc9154a2f40df8dcaa61493fe4d89

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ec4cc9154a2f40df8dcaa61493fe4d89

Other Identifiers

ISSN

1471-230X

E-ISSN

1471-230X

DOI

10.1186/s12876-023-02674-x

How to access this item